dc.creatorGonzález, Benito
dc.creatorHernández, P.
dc.creatorOlguín, H.
dc.creatorMiranda, M.
dc.creatorLira, L.
dc.creatorToso, M.
dc.creatorQuezada, A.
dc.creatorNorambuena, X.
dc.creatorTalesnik, E.
dc.creatorMéndez, C.
dc.creatorNavarrete, C.
dc.date.accessioned2019-01-29T17:57:02Z
dc.date.available2019-01-29T17:57:02Z
dc.date.created2019-01-29T17:57:02Z
dc.date.issued2005
dc.identifierLupus, Volumen 14, Issue 11, 2018, Pages 918-923
dc.identifier09612033
dc.identifier10.1191/0961203303lu2183xx
dc.identifierhttps://repositorio.uchile.cl/handle/2250/163910
dc.description.abstractThe objective of this study was to analyse the survival rate and cause of death in children with systemic lupus erythematosus (SLE) during the past 30 years in Chile. A retrospective analysis was performed between 1969 and 2000 on patients attending pediatric rheumatology centres in Santiago, Chile. Survival and causes of death in 31 children followed from 1969 to 1980 fulfilling the 1982 American College of Rheumatology criteria for SLE and treated with oral steroids were compared with 50 other patients who were treated with oral steroids and an aggressive treatment of IV bolus of cyclophosphamide (38 patients) and azathioprine (12 patients). Global survival at five and 10 years follow-up for the patients studied from 1969 to 1980 was 68 and 40%, respectively. During the second study period these values were significantly improved and global survival reached 95% at five years and 90% at 10 years follow-up (P < 0.05). Survival at 10 years follow-up for patients with lupus nephropathy i
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceLupus
dc.subjectChildhood
dc.subjectChile
dc.subjectSurvival
dc.subjectSystemic lupus erythematosus
dc.titleChanges in the survival of patients with systemic lupus erythematosus in childhood: 30 Years experience in Chile
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución